SMAD4 and cancer: While the involvement of STAT3 in cancer has been predominantly associated with chronic inflammation and fibrosis (Laklai et al., 2016; Ji et al., 2019), our data underscore the significance of epistasis as a key factor that underlies functional antagonism between STAT3 and TGF-β/SMAD4 signaling.